Research


April 18, 2025

UAMS Showcase for Medical Discoveries Focuses on Digital Health, Collaboration

Benjamin Waldrum

Stefanie Kennon-McGill presenting at UAMS Showcase for Medical Discoveries 2025

Amidst the digital health initiatives on display during the latest research showcase at the University of Arkansas for Medical Sciences (UAMS) was the opportunity for good, old-fashioned collaboration. Approximately 40 people attended the UAMS Showcase of Medical Discoveries, held April 9 on the 10th floor of the UAMS Winthrop P. Rockefeller Cancer Institute in Little…


April 15, 2025

UAMS, CDC Find 3% of Arkansas 8-Year-Olds, 2.5% of 4-Year-Olds Diagnosed with Autism

News Staff

One in 34 (3.0%) of 8-year-old children in Arkansas were identified with autism spectrum disorder by the University of Arkansas for Medical Sciences’ (UAMS) Arkansas Autism and Developmental Disabilities Monitoring (AR ADDM) program in 2022.

LITTLE ROCK — One in 34 (3.0%) of 8-year-old children in Arkansas were identified with autism spectrum disorder by the University of Arkansas for Medical Sciences’ (UAMS) Arkansas Autism and Developmental Disabilities Monitoring (AR ADDM) program in 2022, according to an analysis published April 15 in the U.S. Centers for Disease Control and Prevention’s (CDC) Morbidity and Mortality Weekly Report (MMWR) Surveillance Summaries.


March 31, 2025

NIH Awards UAMS Nearly $3 Million to Study DNA Structures that Could Impact Cancer Treatment

David Robinson

Kevin Raney, Ph.D. (center), is leading exciting new research of unique DNA structures called quadruplexes with his team (l-r): Yu Chen, research assistant, Jun Gao, Ph.D., instructor Kirk West, Ph.D., assistant professor, Farhana Nasrin, Ph.D., assistant staff scientist, and John Marecki, Ph.D., instructor.

LITTLE ROCK — University of Arkansas for Medical Sciences (UAMS) researcher Kevin Raney, Ph.D., has been awarded a five-year, $2.99 million grant from the National Institutes of Health (NIH) to study unusual DNA structures called quadruplexes, which may act like natural drugs by binding to key proteins involved in disease. The grant from the NIH…


March 14, 2025

70 Years after Discovery, UAMS Myeloma Center, Castleman Disease Collaborative Network Lead the Way in Understanding Disease

News Staff

Frits van Rhee, David Fajgenbaum

By Frits van Rhee, M.D., Ph.D. Castleman disease was first described in 1954 by Benjamin Castleman, M.D., longtime chief of the Division of Anatomic Pathology at Massachusetts General Hospital in Boston. Patients with Castleman disease have enlargement of one or more lymph node areas. Patients who have the disease in one area, unicentric Castleman disease,…


Funding Awards Amplify Myeloma Research

Nathan Tidwell

Frank Zhan

At the UAMS Myeloma Center, Fenghuang (Frank) Zhan, M.D., Ph.D., knows that research plays an immensely important role in the fight against multiple myeloma. Numerous federal grants allow the center’s director of research and his team to continue to advance and improve treatments, benefitting myeloma patients around the world. The latest is a $1.1 million…


Myeloma Center Focuses on Immunotherapy Drugs in Latest Clinical Trials

Nathan Tidwell

Schinke, Al Hadidi

Multiple myeloma treatment is advancing with the advent of bispecific antibody drugs, which use the patient’s T cells to fight the disease. Myeloma Center physicians and researchers Carolina Schinke, M.D., and Samer Al Hadidi, M.D., M.S., are leading clinical trials exploring combinations of these novel therapies. Schinke’s trial is studying the effects of using teclistamab…


March 13, 2025

UAMS Joins NIH Effort to Increase Rural Health Research

David Robinson

Physicians at UAMS Regional Campuses, including Jacquelene Childs, M.D., at the UAMS Family Medical Center in El Dorado, will play key roles in expanding rural research as part of the CARE for Health™ program.

LITTLE ROCK — The University of Arkansas for Medical Sciences (UAMS) has joined a network of institutions funded by the National Institutes of Health (NIH) to expand research in rural primary care clinics. Through the NIH CARE for Health™ initiative, UAMS will help lead innovative research to address health disparities in Arkansas’ rural areas. UAMS,…


March 12, 2025

UAMS Doctor Receives VA Merit Award to Address Overprescribing of Thyroid Medication

David Robinson

UAMS’ Spyridoula Maraka, M.D., will implement strategies that she hopes will reduce overprescribing of the common thyroid medication levothyroxine (LT4).

UAMS’ Spyridoula Maraka, M.D., has been awarded a Veterans Affairs (VA) Merit Award of $830,000 over four years to address the widespread overprescribing of levothyroxine (LT4), one of the most prescribed drugs in the United States. LT4 is used to treat hypothyroidism, a condition where the thyroid produces too few hormones. However, many patients are…


February 19, 2025

Three UAMS Researchers Awarded BioVentures LLC Accelerator Grants

David Robinson

The 2025 AR Health Ventures Accelerator (ARHVA) grant recipients are: (l-r) John Arthur, M.D., Ph.D., Zachary Waldrip, Ph.D., and Marie Burdine, Ph.D.

BioVentures LLC at the University of Arkansas for Medical Sciences (UAMS) has announced three researchers as recipients of grants from the 2025 AR Health Ventures Accelerator (ARHVA), a program that supports the development of innovative drugs, diagnostics and devices. The 2025 grant recipients are: John Arthur, M.D., Ph.D., a professor and chief of the Division…


February 14, 2025

Arkansas Center for Birth Defects Research and Prevention Highlighted at Research Showcase

Kev' Moye

Researcher

The Arkansas Center for Birth Defects Research and Prevention took center stage in the University of Arkansas for Medical Sciences (UAMS) Division of Research and Innovation’s latest Showcase of Medical Discoveries. The center in the UAMS Fay W. Boozman College of Public Health aims to understand the causes of birth defects and to reduce the…



Next page